Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Borgå

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
Journal of Pharmacokinetics and Biopharmaceutics|February 1, 1997
Serum protein binding of nonsteroidal antiinflammatory drugs: a comparative studyO Borgå, B Borgå
European Journal of Clinical Pharmacology|January 1, 1987
Enprofylline pharmacokinetics in children with asthmaC Hultqvist, O Borgå
European Journal of Clinical Pharmacology|January 1, 1987
Pharmacokinetics of enprofylline in healthy elderly subjectsE Lunell, O Borgå
European Journal of Respiratory Diseases. Supplement|January 1, 1984
Pharmacokinetic implications of slow equilibration of terbutaline between plasma and erythrocytesO Borgå, C Lindberg
Clinical Pharmacology and Therapeutics|November 1, 1977
Plasma protein binding of basic drugs. II. Importance of alpha 1-acid glycoprotein for interindividual variationK M Piafsky, O Borgå
European Journal of Clinical Pharmacology|January 1, 1976
Lack of relationship between serum free fatty acids and impaired plasma protein binding of diphenylhydantoin in chronic renal failureI Odar-Cederlöf, O Borgå
European Journal of Clinical Pharmacology|January 1, 1984
Pharmacokinetics of enprofylline in patients with impaired renal function after a single intravenous doseE Lunell, O Borgå, R Larsson
European Journal of Clinical Pharmacology|January 1, 1986
Effects of probenecid on enprofylline kinetics in manO Borgå, R Larsson, E Lunell
European Journal of Clinical Pharmacology|January 1, 1983
Protein binding of enprofyllineK Tegnér, O Borgå, I Svensson
Clinical Pharmacology and Therapeutics|June 1, 1979
Renal excretion of cephapirin and cephaloridine: evidence for saturable tubular reabsorptionA Arvidsson, O Borgå, G Alván
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Journal of Pharmacokinetics and Biopharmaceutics|February 1, 1997
Serum protein binding of nonsteroidal antiinflammatory drugs: a comparative studyO Borgå, B Borgå
European Journal of Clinical Pharmacology|January 1, 1987
Enprofylline pharmacokinetics in children with asthmaC Hultqvist, O Borgå
European Journal of Clinical Pharmacology|January 1, 1987
Pharmacokinetics of enprofylline in healthy elderly subjectsE Lunell, O Borgå
European Journal of Respiratory Diseases. Supplement|January 1, 1984
Pharmacokinetic implications of slow equilibration of terbutaline between plasma and erythrocytesO Borgå, C Lindberg
Clinical Pharmacology and Therapeutics|November 1, 1977
Plasma protein binding of basic drugs. II. Importance of alpha 1-acid glycoprotein for interindividual variationK M Piafsky, O Borgå
European Journal of Clinical Pharmacology|January 1, 1976
Lack of relationship between serum free fatty acids and impaired plasma protein binding of diphenylhydantoin in chronic renal failureI Odar-Cederlöf, O Borgå
European Journal of Clinical Pharmacology|January 1, 1984
Pharmacokinetics of enprofylline in patients with impaired renal function after a single intravenous doseE Lunell, O Borgå, R Larsson
European Journal of Clinical Pharmacology|January 1, 1986
Effects of probenecid on enprofylline kinetics in manO Borgå, R Larsson, E Lunell
European Journal of Clinical Pharmacology|January 1, 1983
Protein binding of enprofyllineK Tegnér, O Borgå, I Svensson
Clinical Pharmacology and Therapeutics|June 1, 1979
Renal excretion of cephapirin and cephaloridine: evidence for saturable tubular reabsorptionA Arvidsson, O Borgå, G Alván
Pageof 4